Cancer
Malignant Gastric Neoplasm
CI-CAN-00001130Explore in graph →
Top-level652 active trials4 approved drugs55 evidence items
Loading cancer entity…
Loading cancer entity…
Cancer
CI-CAN-00001130Explore in graph →
Clinical trials
2,842 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (232)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00941655 | Prospective Randomized Trial Comparing Gastrectomy, Metastasectomy Plus Systemic Therapy Versus Systemic Therapy Alone: GYMSSA Trial | completed | Phase 3 | 15 | National Cancer Institute (NCI)NIH | 1 | Nov 13, 2019 | clinicaltrials |
| NCT00917384 | Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Participants With Gastric Cancer and Adenocarcinoma | completed | Phase 3 | 355 | Eli Lilly and CompanyINDUSTRY | 30 | Sep 25, 2019 | clinicaltrials |
| NCT01170663 | A Study of Paclitaxel With or Without Ramucirumab (IMC-1211B) in Metastatic Gastric Adenocarcinoma(RAINBOW) | completed | Phase 3 | 665 | Eli Lilly and CompanyINDUSTRY | 26 | Sep 18, 2019 | clinicaltrials |
| NCT01216644 | 5-FU, Leucovorin, Oxaliplatin and Docetaxel (FLOT) Versus Epirubicin, Cisplatin and 5-FU (ECF) in Patients With Locally Advanced, Resectable Gastric Cancer | completed | Phase 2 / Phase 3 | 716 | Krankenhaus NordwestOTHER | 1 | Jun 19, 2019 | clinicaltrials |
| NCT02647476 | Postoperative Enteral Immunonutrition in Gastric Cancer | completed | Phase 3 | 98 | Jagiellonian UniversityOTHER | 1 | Feb 27, 2019 | clinicaltrials |
| NCT02490111 | Clinical Trials for the Prevention of Gallstone Formation After Gastrectomy in Patient With Gastric Cancer | completed | Phase 3 | 521 | Daewoong Pharmaceutical Co. LTD.INDUSTRY | 1 | Feb 8, 2019 | clinicaltrials |
| NCT03350477 | Bioinformation Therapy for Gastric Cancer | completed | Phase 2 / Phase 3 | 120 | Fuda Cancer Hospital, GuangzhouOTHER | 1 | Jan 25, 2019 | clinicaltrials |
| NCT01824459 | S-1+Oxaliplatin vs.S-1+Cisplatin First-line Treatment of Advanced or Recurrent Non-intestinal Type Gastric Adenocarcinoma Patients | completed | Phase 3 | 576 | Sun Yat-sen UniversityOTHER | 1 | Jan 23, 2019 | clinicaltrials |
| NCT02120885 | An Effect of an Individualized Physical Activity Intervention for Gastric Cancer Patient Undergoing Minimally Invasive Gastrectomy: a Phase III, Prospective Randomized Controlled Trial(Gastric cancer) | completed | Phase 3 | 70 | Yonsei UniversityOTHER | 1 | Jan 22, 2019 | clinicaltrials |
| NCT01065688 | A Trial of Reconstruction After Distal Gastrectomy for Gastric Cancer | completed | Phase 3 | 120 | Wakayama Medical UniversityOTHER | 1 | Oct 9, 2018 | clinicaltrials |
| NCT02706184 | E. Coli Nissle in Oncology(EcNO) | completed | Phase 3 | 20 | University of HohenheimOTHER | 1 | May 15, 2018 | clinicaltrials |
| NCT00887822 | A Study of Bevacizumab (Avastin) Versus Placebo in Combination With Capecitabine (Xeloda) and Cisplatin as First-Line Therapy for Advanced Gastric Cancer(AVATAR) | completed | Phase 3 | 202 | Hoffmann-La RocheINDUSTRY | 1 | Mar 1, 2017 | clinicaltrials |
| NCT01099085 | Trial of XP (Capecitabine/CDDP) Simvastatin in Advanced Gastric Cancer Patients | completed | Phase 3 | 207 | Samsung Medical CenterOTHER | 1 | Feb 17, 2017 | clinicaltrials |
| NCT02988635 | Early Palliative Care on Quality of Life of Advanced Cancer Patients | completed | Phase 3 | 281 | Azienda Ospedaliero-Universitaria di ParmaOTHER | 0 | Dec 9, 2016 | clinicaltrials |
| NCT01662869 | A Study of Onartuzumab in Combination With mFOLFOX6 in Participants With Metastatic HER2-Negative and MET-Positive Gastroesophageal Cancer | completed | Phase 3 | 564 | Hoffmann-La RocheINDUSTRY | 24 | Nov 2, 2016 | clinicaltrials |
| NCT02560974 | A Study of Capecitabine (Xeloda) in Combination Chemotherapy Versus Surgery Alone in Participants With Gastric Cancer | completed | Phase 3 | 1,035 | Hoffmann-La RocheINDUSTRY | 3 | Nov 2, 2016 | clinicaltrials |
| NCT02563054 | A Study of Capecitabine (Xeloda) in Participants With Advanced or Metastatic Gastric Cancer | completed | Phase 3 | 316 | Hoffmann-La RocheINDUSTRY | 14 | Nov 2, 2016 | clinicaltrials |
| NCT00142350 | A Study of 5-FUci Versus CPT-11 Plus CDDP Versus S-1 Alone in Advanced Gastric Cancer | completed | Phase 3 | 690 | Japan Clinical Oncology GroupOTHER | 1 | Sep 12, 2016 | clinicaltrials |
| NCT00216034 | Randomized Controlled Study of Postoperative Adjuvant Therapy for Gastric Cancer Using TS-1 or TS-1+PSK | completed | Phase 3 | 255 | Hokuriku-Kinki Immunochemotherapy Study GroupOTHER | 1 | Jun 7, 2016 | clinicaltrials |
| NCT01671449 | S-1 and Cisplatin (3 Weekly) Versus S-1 and Oxaliplatin Combination Chemotherapy for Advanced Gastric Cancer(SOPP) | completed | Phase 3 | 338 | Min-Hee RyuOTHER | 1 | Nov 30, 2015 | clinicaltrials |
| NCT00879333 | Safety and Efficacy of RAD001 (Everolimus) Monotherapy Plus Best Supportive Care in Patients With Advanced Gastric Cancer (AGC)(GRANITE-1) | completed | Phase 3 | 656 | Novartis PharmaceuticalsINDUSTRY | 22 | Nov 3, 2015 | clinicaltrials |
| NCT02219529 | Magnetic-controlled Capsule Endoscopy vs. Gastroscopy for Detection of Gastric Diseases(MCE) | completed | Phase 3 | 350 | Changhai HospitalOTHER | 1 | Jul 21, 2015 | clinicaltrials |
| NCT02444897 | The Comparison Between Epidural and Intravenous Patient-controlled Analgesia for Laparoscopic Gastrectomy | completed | Phase 3 | 60 | Keimyung University Dongsan Medical CenterOTHER | 1 | May 15, 2015 | clinicaltrials |
| NCT00718354 | Overall Survival of Inoperable Gastric/GastroOesophageal Cancer Subjects on Treating With LMWH + Chemotherapy(CT) vs Standard CT(GASTRANOX) | completed | Phase 3 | 740 | Thrombosis Research InstituteOTHER | 1 | May 13, 2015 | clinicaltrials |
| NCT02442362 | TOF Versus SOX in Metastatic Gastric Cancer | completed | Phase 2 / Phase 3 | 60 | The First People's Hospital of ChangzhouOTHER | 0 | May 13, 2015 | clinicaltrials |
| NCT01041404 | ToGA Study - A Study of Herceptin (Trastuzumab) in Combination With Chemotherapy Compared With Chemotherapy Alone in Patients With HER2-Positive Advanced Gastric Cancer | completed | Phase 3 | 584 | Hoffmann-La RocheINDUSTRY | 24 | Nov 5, 2014 | clinicaltrials |
| NCT00678535 | Erbitux in Combination With Xeloda and Cisplatin in Advanced Esophago-gastric Cancer(EXPAND) | completed | Phase 3 | 904 | Merck KGaA, Darmstadt, GermanyINDUSTRY | 25 | Jul 21, 2014 | clinicaltrials |
| NCT00296335 | Trial of Adjuvant Chemotherapy for Gastric Cancer | completed | Phase 3 | 855 | Asan Medical CenterOTHER | 1 | Feb 27, 2014 | clinicaltrials |
| NCT00002615 | Surgery With or Without Combination Chemotherapy in Treating Patients With Stomach Cancer | completed | Phase 3 | 500 | Medical Research CouncilOTHER_GOV | 1 | Dec 19, 2013 | clinicaltrials |
| NCT01971775 | Clinical Study for Energy Based Devices in Open Gastrectomy for Gastric Cancer | completed | Phase 3 | 56 | Seoul National University HospitalOTHER | 1 | Oct 29, 2013 | clinicaltrials |
| NCT01491698 | Impact of Roux-En-Y Pouch Reconstruction Compared With Conventional Roux-En-Y Reconstruction on Health-Related Quality of Life in Patients Undergoing Total Gastrectomy for Adenocarcinoma | completed | Phase 3 | 12 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Aug 15, 2013 | clinicaltrials |
| NCT00978549 | Symptom Control With or Without Docetaxel in Treating Patients With Relapsed Esophageal Cancer or Stomach Cancer | completed | Phase 3 | 320 | Cambridge University Hospitals NHS Foundation TrustOTHER | 1 | Aug 7, 2013 | clinicaltrials |
| NCT00182611 | S-1 and Cisplatin in Treating Patients Who Are Undergoing Surgery for Stage III Stomach Cancer | completed | Phase 3 | 100 | Kyoto UniversityOTHER | 1 | Jun 26, 2013 | clinicaltrials |
| NCT00123318 | A Feasibility Study to Evaluate Adjuvant Chemoradiotherapy for Gastric Cancer | completed | Phase 3 | 52 | Trans Tasman Radiation Oncology GroupOTHER | 2 | Jun 18, 2013 | clinicaltrials |
| NCT01411176 | Phase III Study of NPO-11 in Patients Undergoing Therapeutic Upper Gastrointestinal Endoscopy | completed | Phase 3 | 85 | Nihon Pharmaceutical Co., LtdINDUSTRY | 1 | Jun 29, 2012 | clinicaltrials |
| NCT01411189 | Phase III Open-labeled Study of NPO-11 in Patients Undergoing Therapeutic Upper Gastrointestinal Endoscopy | completed | Phase 3 | 33 | Nihon Pharmaceutical Co., LtdINDUSTRY | 1 | Jun 29, 2012 | clinicaltrials |
| NCT00546468 | Clinical Study on Laparoscopic Gastrectomy for Early Gastric Cancer (COACT_0301)(NCC052) | completed | Phase 3 | 164 | National Cancer Center, KoreaOTHER_GOV | 1 | May 24, 2012 | clinicaltrials |
| NCT00005060 | Combination Chemotherapy and Surgery in Treating Patients With Locally Advanced Stomach Cancer | completed | Phase 3 | 240 | Swiss Cancer InstituteOTHER | 2 | May 15, 2012 | clinicaltrials |
| NCT00821990 | Second-line Therapy Versus Supportive Care for Pretreated Advanced Gastric Cancer | completed | Phase 3 | 200 | Samsung Medical CenterOTHER | 1 | Jan 20, 2012 | clinicaltrials |
| NCT00313872 | Phase III Trial of DP Followed by FOLFIRI or the Reverse Sequence in Unresectable Gastric Cancer | completed | Phase 3 | 200 | Samsung Medical CenterOTHER | 1 | Jan 12, 2012 | clinicaltrials |
| NCT00323830 | Phase III Randomized Trial of Adjuvant XP Chemotherapy and XP/RT for Resected Gastric Adenocarcinoma | completed | Phase 3 | 458 | Samsung Medical CenterOTHER | 1 | Nov 9, 2011 | clinicaltrials |
| NCT00374036 | Metastatic Gastric Cancer FFCD 03-07 | completed | Phase 3 | 416 | University Hospital, ToulouseOTHER | 1 | Oct 12, 2011 | clinicaltrials |
| NCT00970138 | Apatinib Versus Placebo as a Third Line Treatment in Patients With Advanced or Metastatic Gastric Cancer | completed | Phase 2 / Phase 3 | 141 | Fudan UniversityOTHER | 1 | Jul 12, 2011 | clinicaltrials |
| NCT00150670 | Randomized Phase III Study of TS-1 Alone Versus TS-1 Plus CDDP in Advanced Gastric Cancer | completed | Phase 3 | 300 | Taiho Pharmaceutical Co., Ltd.INDUSTRY | 1 | Jul 7, 2011 | clinicaltrials |
| NCT00152217 | Adjuvant Chemotherapy Trial of TS-1 for Gastric Cancer (ACTS-GC) | completed | Phase 3 | 1,000 | Taiho Pharmaceutical Co., Ltd.INDUSTRY | 1 | Jul 7, 2011 | clinicaltrials |
| NCT00152243 | A Randomized Controlled Study of Postoperative Adjuvant Chemotherapy of Uracil- Tegafur (UFT) Compared With Surgery Alone (NSAS-GC) | completed | Phase 3 | 500 | Taiho Pharmaceutical Co., Ltd.INDUSTRY | 1 | Jul 7, 2011 | clinicaltrials |
| NCT00202969 | Study of S-1, S-1/CDDP, and 5-FU/CDDP for Advanced Gastric Cancer | completed | Phase 3 | 180 | Taiho Pharmaceutical Co., Ltd.INDUSTRY | 1 | Jul 7, 2011 | clinicaltrials |
| NCT00287768 | Phase III Study of Docetaxel + S-1 vs. S-1 for Advanced Gastric Cancer | completed | Phase 3 | 628 | Japan Clinical Cancer Research OrganizationOTHER | 1 | Jun 28, 2011 | clinicaltrials |
| NCT00639327 | Second Line Chemotherapy for S-1 Refractory Advanced Gastric Cancer | completed | Phase 2 / Phase 3 | 300 | Japan Clinical Cancer Research OrganizationOTHER | 1 | Jun 28, 2011 | clinicaltrials |
| NCT00606619 | Effects of Early Oral Feeding After Resection of Gastric Cancer | completed | Phase 3 | 58 | The Catholic University of KoreaOTHER | 1 | May 28, 2010 | clinicaltrials |
Data updated 22 days agoSource updated Nov 13, 2019source: clinicaltrials